false
0000856984
0000856984
2026-06-17
2026-06-17
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of report (date of earliest event reported): June 17, 2026
QHSLab,
Inc.
(Exact
Name of Registrant as Specified in its Charter)
0-19041
(Commission
File No.)
| Nevada |
|
30-1104301 |
(State
of
Incorporation) |
|
(I.R.S.
Employer
Identification
No.) |
| |
|
|
901
Northpoint Parkway Suite 302 West Palm Beach
FL
33407 |
|
33407 |
| (Address of Principal Executive
Offices) |
|
(ZIP Code) |
Registrant’s
telephone number, including area code: (929) 379-6503
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
| ☐ |
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c) |
Securities
registered pursuant to Section 12(g) of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| Common Stock, $0.0001
par value |
|
USAQ |
|
N/A |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
7.01 Regulation FD Disclosure.
Representatives
of QHSLab, Inc. (the “Company”) intend to participate in the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub conference
to be held on June 16-18, 2026, at the Bellagio Resort & Casino in Las Vegas, Nevada. As part of the conference, the Company will
make a presentation utilizing the corporate presentation annexed as Exhibit 99.1 to this Report. The Company also will participate in
scheduled one-on-one meetings and other discussions with institutional investors, broker-dealers, family offices, registered investment
advisers, high-net-worth investors, analysts, and other members of the investment community.
The
purpose of these presentations and meetings is to provide an overview of the Company’s business, strategy, products, market opportunity,
growth initiatives, and financial performance, as well as to increase investor awareness of the Company.
The
information contained in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes
of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference into any filing under the
Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except as expressly set forth by specific reference
in such filing.
This
Current Report on Form 8-K is not intended to be, and shall not be deemed to be, an admission as to the materiality of any information
disclosed herein that is required to be disclosed solely by Regulation FD.
The
Company does not undertake, and expressly disclaims, any obligation to publicly update or revise any forward-looking statements, whether
as a result of new information, future events, or otherwise, except as required by applicable law.
The
Company uses, and intends to continue to use, its website, press releases, and social media channels as means of disclosing information
to investors and the public. These channels include the Company’s website (https://qhslab.com), Twitter/X (https://twitter.com/qhslabinc),
LinkedIn (https://www.linkedin.com/company/65407282/), Facebook (https://www.facebook.com/QHSLabs), and Instagram (https://www.instagram.com/qhslabs/).
Information posted through these channels may be deemed material, and investors and others are encouraged to monitor these communication
channels.
Item
9.01 FINANCIAL STATEMENTS AND EXHIBITS
(d)
Exhibits.
The
exhibits listed in the following Exhibit Index are filed as part of this Current Report on Form 8-K.
| Exhibit
No. |
|
Description |
| 99.1 |
|
QHSLab, Inc. Corporate Presentation June 17, 2026 |
| 104 |
|
Cover Page Interactive
Data File (embedded within the Inline XBRL document). |
SIGNATURES
Pursuant
to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this current report to be signed
on its behalf by the undersigned, thereunto duly authorized.
| Date: June 17, 2026 |
|
| |
|
|
| QHSLab, Inc. |
|
| |
|
|
| |
/s/
Troy Grogan |
|
| Name: |
Troy Grogan |
|
| Title: |
CEO and Chairman |
|